


| Salt Composition: | Calcitonin (Salmon) (200IU) |
| Manufacturer: | Progress Pharma Private Limited |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Knoglina Nasal Spray is a medicine used for the treatment of osteoporosis in postmenopausal women, making bones stronger and lowering the risk of fractures. Knoglina Nasal Spray is a medicine used for the treatment of osteoporosis in postmenopausal women. It makes the bones stronger and lowers the risk of fractures. It may also be used for bone pain associated with Paget's disease.
Knoglina Nasal Spray is a calcitonin receptor agonist. It acts by suppressing the activity of osteoclasts cells that cause destruction of bone, thereby strengthening the bones and minimizing the risk of fractures.
Use it as advised by your doctor or check the label for directions before use.
Alcohol
No interaction found/established
Breastfeed
Knoglina Nasal Spray is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Knoglina Nasal Spray may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.